Saturday, October 3, 2026

USD/EUR Over 2% Down In The Last 21 Sessions

USD/EUR Over 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.42% for the last 21 sessions. At 17:11 EST on Sunday, 9 April, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 1.114% up from its 52-week low and 12.517% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.08%, a negative 0.12%, and a positive 0.46%, respectively.

USD/EUR's highest amplitude of average volatility was 0.55% (last week), 0.52% (last month), and 0.46% (last quarter), respectively.

News about

  • Usd/jpy surges to a 3-day high on sluggish US nonfarm payrolls report. According to FXStreet on Friday, 7 April, "On its way north, the USD/JPY cleared the R1 daily pivot point at 132.18 but fell short of testing the R2 pivot at 132.60. ", "A clear breach of the latter, and the USD/JPY could test April 4 133.16 daily high before challenging the R3 pivot at 133.31. "
  • According to FXStreet on Friday, 7 April, "Following the news, USD/JPY pares the previous day's rebound, down 0.10% around the intraday low of 131.61.", "It's worth noting that Good Friday holidays in major markets, except for Japan, allow the USD/JPY pair to remain active and consolidate recent gains while being on the way to posting a weekly loss."
  • Usd/jpy ignores yields to slip beneath 132.00 as Japan’s real wages drop at a slower pace, US NFP eyed. According to FXStreet on Friday, 7 April, "Above all, the divergence between the upbeat Japan data and disappointing US statistics keeps the USD/JPY pair on the bear's table. ", "Although the 50-DMA restricts immediate USD/JPY upside to around 133.15, USD/JPY bears need validation from an upward-sloping support line from mid-January, close to 131.30 by the press time."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com